KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
13.38
-0.12 (-0.89%)
At close: Sep 17, 2025, 4:00 PM EDT
13.57
+0.19 (1.42%)
After-hours: Sep 17, 2025, 7:50 PM EDT
KalVista Pharmaceuticals Employees
KalVista Pharmaceuticals had 270 employees as of April 30, 2025. The number of employees increased by 120 or 80.00% compared to the previous year.
Employees
270
Change (1Y)
120
Growth (1Y)
80.00%
Revenue / Employee
$5,281
Profits / Employee
-$752,211
Market Cap
677.77M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Apr 30, 2025 | 270 | 120 | 80.00% |
Apr 30, 2024 | 150 | 32 | 27.12% |
Apr 30, 2023 | 118 | 13 | 12.38% |
Apr 30, 2022 | 105 | 35 | 50.00% |
Apr 30, 2021 | 70 | 14 | 25.00% |
Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
KALV News
- 6 days ago - KalVista Pharmaceuticals, Inc. (KALV) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 6 days ago - KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results - Business Wire
- 7 days ago - KalVista Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 9 days ago - KalVista Pharmaceuticals, Inc. (KALV) Presents At Cantor Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 13 days ago - KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025 - Business Wire
- 13 days ago - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 21 days ago - KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025 - Business Wire
- 5 weeks ago - Metagenomi Appoints Laurence Reid, PhD to its Board of Directors - GlobeNewsWire